Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenuit Group Regulatory News (GEN)

Share Price Information for Genuit Group (GEN)

Share Price is delayed by 15 minutes
Get Live Data
256.80    4.80 (1.90%)
Bid:
256.20
Ask:
256.80
Spread: 0.60 (0.234%)
Market Cap: £647.10m
GEN Live PriceLast checked at - London Stock Exchange

Intraday Genuit Group Share Chart

Directorate Change

29 Nov 2021 08:01

RNS Number : 8026T
Genuit Group PLC
29 November 2021
 

29 November 2021

Genuit Group plc

Appointment of Chief Executive Officer

 

Following its announcement on 20 May 2021, Genuit Group plc (the "Company" or the "Group") is pleased to announce that Joe Vorih will be appointed as Chief Executive Officer (CEO) and a member of the Board early in 2022, on a date to be confirmed in due course.

Joe will join Genuit Group's Board from Spectris plc, a FTSE 250 company, where he has been president of HBK, a standalone division and key platform business within the Group, since January 2019, having joined Spectris in 2016. Prior to that, he worked for Clarcor Corporation, a NYSE listed business delivering filtration solutions and Danaher Corporation, also a US listed global business in industrial, test and medical equipment.

The Company confirms that as previously announced, Martin Payne will step down from the Board and as CEO following a period of handover with Mr Vorih, but will remain an employee of the Company and available to the Board in an advisory capacity until 20 May 2022.

Ron Marsh, Genuit Group Chairman, commented: "Joe is a highly experienced senior executive with a strong track record. Joe brings extensive operational leadership and strategic expertise in the manufacturing and technology industries, and I am confident he will take Genuit Group forward to the next stage of its growth and development."

Joe Vorih commented, "I am delighted to have been appointed CEO of Genuit Group at such an exciting time in its development. I look forward to working alongside the Board and leading the Executive Team to continue to deliver a strong performance across the Group and drive the strategy forwards."

There is no information concerning Mr Vorih which requires notification under LR9.6.13R of the Financial Conduct Authority's Listing Rules.

 

Enquiries:

 Genuit Group

 Ron Marsh, Chairman

 Paul James, Chief Financial Officer

+44 (0) 1138 315380

 Brunswick

 Nina Coad

 Sophia Lazarus

+44 (0) 20 7404 5959

 

Notes to Editors:

Genuit Group plc ("Genuit" or the "Group"), a leading provider of sustainable water and climate management solutions for the built environment, is the largest manufacturer in the UK, and among the ten largest manufacturers in Europe, of piping systems for the residential, commercial, civils and infrastructure sectors by revenue. It is also a leading designer and manufacturer of energy efficient ventilation systems in the UK.

 

The Group operates from 28 facilities in total, and manufactures the UK's widest range of solutions for heating, plumbing, drainage and ventilation. The Group primarily targets the UK and European building and construction markets with a presence in Italy, the Netherlands, Ireland and the Middle East and sales to specific niches in the rest of the world.

Genuit Group plc changed its corporate name from Polypipe Group plc on 6 April 2021. The Group was established in 1980 and has been listed on the London Stock Exchange since 2014.  

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFFEILRLTFIL
Date   Source Headline
2nd Jun 20261:15 pmRNSDirector/PDMR Shareholding
29th May 20262:39 pmRNSTotal Voting Rights
29th May 20262:23 pmRNSHolding(s) in Company
29th May 20261:59 pmRNSDirector/PDMR Shareholding
28th May 20262:24 pmRNSHolding(s) in Company
27th May 202610:07 amRNSDirector/PDMR Shareholding
26th May 20263:49 pmRNSHolding(s) in Company
22nd May 20263:01 pmRNSResult of AGM
22nd May 20267:00 amRNSTrading Update
5th May 20269:00 amRNSDirector/PDMR Shareholding
1st May 20264:12 pmRNSDirector/PDMR Shareholding
30th Apr 20264:26 pmRNSAdmission to Trading
30th Apr 20264:17 pmRNSTotal Voting Rights
30th Apr 20264:06 pmRNSDirector/PDMR Shareholding
27th Apr 20264:20 pmRNSHolding(s) in Company
14th Apr 20264:32 pmRNSDirector/PDMR Shareholding
14th Apr 202610:11 amRNSNotice of AGM
10th Apr 20261:34 pmRNSBlock Listing Application
7th Apr 20269:58 amRNSHolding(s) in Company
1st Apr 202610:00 amRNSDirector/PDMR Shareholding
31st Mar 20266:01 pmRNSTotal Voting Rights
23rd Mar 20263:25 pmRNSHolding(s) in Company
20th Mar 20261:43 pmRNSDirector/PDMR Shareholding
13th Mar 20269:41 amRNSHolding(s) in Company
13th Mar 20269:41 amRNSHolding(s) in Company
11th Mar 20262:12 pmRNSFull-Year 2025 Results Investor Q&A
10th Mar 20267:00 amRNSFinal Results
6th Mar 202611:35 amRNSHolding(s) in Company
5th Mar 20262:46 pmRNSHolding(s) in Company
5th Mar 20262:41 pmRNSHolding(s) in Company
4th Mar 20262:40 pmRNSHolding(s) in Company
3rd Mar 20263:51 pmRNSHolding(s) in Company
2nd Mar 20265:25 pmRNSHolding(s) in Company
27th Feb 20263:18 pmRNSTotal Voting Rights
30th Jan 20266:00 pmRNSTotal Voting Rights
29th Jan 202610:17 amRNSHolding(s) in Company
29th Jan 202610:15 amRNSHolding(s) in Company
29th Jan 202610:06 amRNSHolding(s) in Company
12th Jan 20265:41 pmRNSHolding(s) in Company
31st Dec 202510:00 amRNSTotal Voting Rights
31st Dec 202510:00 amRNSTotal Voting Rights
23rd Dec 20259:08 amRNSHolding(s) in Company
23rd Dec 20259:08 amRNSHolding(s) in Company
23rd Dec 20259:06 amRNSHolding(s) in Company
23rd Dec 20259:06 amRNSHolding(s) in Company
16th Dec 20252:03 pmRNSHolding(s) in Company
16th Dec 20252:01 pmRNSHolding(s) in Company
12th Dec 20253:41 pmRNSDirector/PDMR Shareholding
10th Dec 20254:11 pmRNSDirector/PDMR Shareholding
9th Dec 202510:44 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.